Australian Clinical Labs Limited (ASX: ACL)
Australia
· Delayed Price · Currency is AUD 3.500
+0.030 (0.86%)
Nov 22, 2024, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 697.49 million as of November 22, 2024. Its market cap has increased by 30.78% in one year.
Market Cap
697.49M
Enterprise Value
979.78M
Revenue
696.37M
Ranking
n/a
PE Ratio
29.17
Stock Price
3.50
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has increased from 690.27M to 697.49M, an increase of 1.05%. That is a compound annual growth rate of 0.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 682.41M | 17.77% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 133.87B |
| ResMed Inc. | 54.90B |
| Pro Medicus Limited | 23.17B |
| Fisher & Paykel Healthcare Corporation Limited | 20.33B |
| Cochlear Limited | 19.52B |
| Sonic Healthcare Limited | 13.43B |
| Ramsay Health Care Limited | 8.95B |
| Telix Pharmaceuticals Limited | 7.56B |